Piotr Widera

Piotr Widera

Auto-generated profile, based on publicly available information

Piotr Widera

Medical University of Silesia in Katowice, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PJPaulina Jakubczyk
Paulina Jakubczyk
PWPiotr Widera
Piotr Widera
JHJustyna Helis
Justyna Helis
MMMaciej Michalik
Maciej Michalik
ABAleksandra Buczek
Aleksandra Buczek
MHMarta Handschuh
Marta Handschuh
Aim of the StudyThis review investigates the relationship between physical activity and inflammatory bowel disease (IBD), focusing on inflammatory markers, gut microbiota composition, and disease activity. The objective is to examine how exercise intensities influence inflammation, microbial diversity, and patient outcomes for IBD management. Materials and MethodsA literature review synthesized peer-reviewed studies from 2010-2024 using PubMed, Scopus, and Embase databases, examining physical activity effects on inflammatory markers, gut microbiota, and clinical outcomes in IBD patients. Inclusion criteria emphasized human studies, excluding research unrelated to IBD or focused on animal models. State of KnowledgeModerate-intensity aerobic and resistance exercises reduce systemic inflammatory markers, (CRP and cytokines) and enhance gut microbiota diversity, increasing anti-inflammatory species. Low-to-moderate intensity activities improve quality of life in IBD patients. Exercise supports intestinal barrier integrity through mucin production and fatty acid synthesis. High-intensity exercise can worsen inflammation, necessitating tailored protocols. ConclusionsPhysical activity is a promising adjunctive therapy in IBD management. Moderate-intensity programs effectively maintain remission and enhance outcomes. Future research should focus on longitudinal studies, advanced omics technologies, and combined approaches with dietary and pharmacological therapies.

14 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
HBHubert Bigajski
Hubert Bigajski
ABAleksandra Banaś
Aleksandra Banaś
MMMaciej Michalik
Maciej Michalik
PWPiotr Widera
Piotr Widera
MHMarta Handschuh
Marta Handschuh
ABAleksandra Buczek
Aleksandra Buczek
Introduction and Purpose This review explores physical activity's role in managing urological health, focusing on prostate cancer and overactive bladder (OAB). These conditions significantly affect quality of life globally. The review synthesizes research to identify gaps and propose future directions for clinical practice. Materials and Methods A literature search was conducted using PubMed, MEDLINE, and Cochrane Library databases (2010-2023). The focus was on randomized controlled trials, observational studies, and systematic reviews. Key terms included "physical activity," "prostate cancer," "overactive bladder," and "urological health." Studies were selected based on relevance to exercise interventions in urological conditions. Results High-intensity exercise reduces prostate cancer risk by 10–30% and improves outcomes by enhancing cardiovascular fitness and quality of life. For OAB, low-impact aerobic exercises alleviate symptoms by improving neuromuscular control and reducing inflammation. Mechanisms include hormonal regulation, improved metabolic health, and reduced inflammation. Structured prehabilitation programs with pelvic floor muscle training optimize continence outcomes post-surgery. Conclusions Physical activity is a cost-effective intervention for managing urological health. Despite strong evidence supporting its benefits, gaps remain in understanding optimal exercise prescriptions and long-term effects across diverse populations. Future research should focus on tailoring interventions to patient needs, exploring innovative modalities like high-intensity interval training, and integrating exercise with other treatments to improve outcomes.

30 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MPMarcel Pilarek
Marcel Pilarek
WLWiktoria Laskowska
Wiktoria Laskowska
KKKlaudia Kwolek
Klaudia Kwolek
HBHubert Bigajski
Hubert Bigajski
ABAleksandra Banaś
Aleksandra Banaś
PWPiotr Widera
Piotr Widera
The escalating global mental health burden, affecting an estimated 165 million individuals annually within the European Union, necessitates a fundamental paradigm shift toward digitally-enhanced care models to alleviate systemic strain and limited provider availability. This narrative review provides a holistic socio-technical synthesis of the Digital Mental Health Interventions (DMHI) ecosystem, integrating heterogeneous evidence ranging from randomized controlled trials and meta-analyses to empirical technical software audits. Findings confirm the general non-inferiority of iCBT compared to traditional modalities, although therapeutic efficacy remains highly contingent upon human integration as defined by the Supportive Accountability model. While specialized tools like virtual reality demonstrate superior outcomes for PTSD, severe psychiatric conditions necessitate continued clinical oversight; crucially, a persistent engagement paradox exists wherein high initial adoption is frequently offset by significant long-term attrition. Structurally, the digital inverse care law and the digital divide reinforce systemic health disparities, excluding populations with infrastructure gaps or physical impairments. These systemic inequities are further compounded by an inverse data law, wherein algorithmic datasets remain biased toward healthy populations, leaving marginalized cohorts underrepresented. Furthermore, while digital platforms afford anonymity for managing stigmatized identities, they simultaneously expose vulnerable users to digital microaggressions and prejudice. Ultimately, rapid technological proliferation has outpaced regulatory governance, resulting in privacy vulnerabilities and profound regulatory fragmentation across jurisdictions. DMHI effectiveness is inextricably linked to socio-economic, cultural, and structural contexts, necessitating a transition toward regulated, clinically-led architectures to safeguard social equity and ensure genuine therapeutic value within the digital mental health transition.

27 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
SJSzymon Janczarski
Szymon Janczarski
ABAleksandra Banaś
Aleksandra Banaś
DSDominika Sarna
Dominika Sarna
PWPiotr Widera
Piotr Widera
MMMaciej Michalik
Maciej Michalik
HDHubert Dacyl
Hubert Dacyl
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide and represents a major contributor to stroke, heart failure, and cardiovascular mortality. A significant proportion of AF cases remain asymptomatic, often referred to as "silent AF," which delays diagnosis and increases the risk of severe thromboembolic complications. Conventional diagnostic methods, including standard electrocardiography (ECG) and short-term Holter monitoring, are limited by their episodic nature and reliance on clinical settings, frequently failing to capture intermittent arrhythmic events. In recent years, consumer wearable technologies - particularly smartwatches equipped with photoplethysmography (PPG) sensors and single-lead ECG capabilities - have emerged as promising tools for continuous cardiac rhythm monitoring. This narrative review synthesizes contemporary evidence on the diagnostic accuracy, clinical integration, and behavioral implications of wearable technologies for AF detection. Literature published between 2018 and 2025 was identified through searches of PubMed/MEDLINE, Scopus, and Google Scholar. Studies evaluating sensing technologies, algorithmic approaches, large-scale population trials, and digital health behavior were included. Current evidence demonstrates that wearable devices can achieve high concordance with traditional ECG-based diagnostic methods, with many studies reporting sensitivities and specificities exceeding 90%. Passive PPG monitoring combined with user-initiated ECG confirmation enables scalable detection of previously undiagnosed AF in real-world settings. However, challenges remain, including signal artifacts, false-positive alerts, user adherence, and socioeconomic disparities in device access. Overall, wearable technologies represent a valuable adjunct for early AF detection and long-term rhythm monitoring. Their optimal clinical role lies within hybrid diagnostic pathways that integrate patient-generated data with physician validation and established cardiovascular care frameworks.

26 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
ABAleksandra Banaś
Aleksandra Banaś
HBHubert Bigajski
Hubert Bigajski
SJSzymon Janczarski
Szymon Janczarski
KKKlaudia Kwolek
Klaudia Kwolek
WLWiktoria Laskowska
Wiktoria Laskowska
PWPiotr Widera
Piotr Widera
Continuous glucose monitoring (CGM) represents a paradigm shift in diabetes management, transitioning care from reactive monitoring to proactive glycemic control; however, its adoption remains stratified by deep-seated socioeconomic and structural, and technological inequities. This narrative review synthesizes literature published between 2017 and 2025 to evaluate the clinical efficacy of CGM while interrogating the socio-technical barriers shaping its accessibility. A thematic analysis of current evidence confirms that while CGM significantly improves HbA1c, quality of life, and hypoglycemia reduction across Type 1 and Type 2 diabetes, access to these outcomes is severely constrained by systemic and digital obstacles. Key findings identify a “coverage patchwork” wherein high out-of-pocket costs and administrative hurdles disproportionately restrict access for Medicaid beneficiaries and low-income populations. Furthermore, the review highlights persistent racial disparities driven by provider implicit bias, alongside a “digital divide” where limited connectivity and low eHealth literacy impede effective utilization. Consequently, without intervention, CGM risks functioning as an “accelerator of disparities,” creating a two-tier healthcare system that privileges “data-rich” early adopters while leaving marginalized groups behind. The authors conclude that bridging this gap requires a multifaceted strategy integrating policy reform, inclusive device design, and literacy-centered education to ensure technological innovation advances health equity rather than reinforcing the “Matthew Effect” in diabetes management.

20 April 2026 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
PWPiotr Widera
Piotr Widera
HBHubert Bigajski
Hubert Bigajski
MMMaciej Michalik
Maciej Michalik
ABAleksandra Banaś
Aleksandra Banaś
DSDominika Sarna
Dominika Sarna
WLWiktoria Laskowska
Wiktoria Laskowska